All companies

Alexion Pharmaceuticals Visa Sponsorship

33 open roles · Boston, MA

H-1B sponsor score57 Active
H-1B filings (3 yrs)13535 since Oct 2025
Green cards (3 yrs)20 in FY2026
Median salary$144k54% entry level

Latest openings

141,531applications submittedfor our users this week
Want to work at Alexion Pharmaceuticals? We find your matches and apply.
ApplyBolt finds jobs that match you, tailors your resume to each role, and applies on company sites. If you need sponsorship, we skip postings that say they won't sponsor.
Find & apply for me

Roles they sponsor for H-1B

Most H-1B salaries here fall between $115k and $170k.

Wage levels and the lottery

Level I26%1 entry
Level II29%2 entries
Level III13%3 entries
Level IV32%4 entries

Since the March 2026 registration, the H-1B lottery gives each registration 1 to 4 entries by wage level: Level I gets 1, Level IV gets 4. Most of Alexion Pharmaceuticals's filings are Level IV.

Green cards

FY20242

Certified PERM applications, the employer's first step toward a worker's green card.

Visa the worker held when they applied (FY2024 cases, the last year DOL published it)

H-1B2
  • Manager, Transparency & Compliance Operations1 green cards$111k median
  • Associate Director, Biostatistics1 green cards$205k median

H-1B filings by year

FY202452
FY202548
FY2026 so far35

FY2026 runs Oct 2025 to Sep 2026; DOL data is through Jun 2026.

Where they file

MA65
CT61
MD2
NJ2
NH1

Why it scores 57

  • 41% of filings are for new hires, not renewals
  • 135 filings since FY2024
  • Filings down 17% vs the same months last year
  • 93% USCIS approval rate (FY2023)
  • Filed every year since FY2024

Similar sponsors

Source: Department of Labor LCA and PERM disclosure data through Jun 2026 and the USCIS H-1B Employer Data Hub. A certified LCA is filed before an H-1B petition and a certified PERM before a green card petition. Neither is an approved visa or a current opening. Not legal advice: rules change, so confirm with your DSO, your employer or an immigration attorney.